A total of 70% of all United States end-stage renal disease (ESRD) patients—more than 350,000— are on some form of dialysis.1 Although dialysis is life-saving, the sur-vival, quality-of-life, and cost-saving ben-efits of receiving a transplant over remain-ing on lifetime dialysis have been clearly es...